Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine.
J Infect Dis. 2023 Oct 18;228(8):999-1011. doi: 10.1093/infdis/jiad108.
J Infect Dis. 2023.
PMID: 37079393
Free PMC article.
Clinical Trial.
One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines.
Ilchmann H, Samy N, Reichhardt D, Schmidt D, Powell JD, Meyer TPH, Silbernagl G, Nichols R, Weidenthaler H, De Moerlooze L, Chen L, Chaplin P.
Ilchmann H, et al. Among authors: silbernagl g.
J Infect Dis. 2023 May 12;227(10):1203-1213. doi: 10.1093/infdis/jiac455.
J Infect Dis. 2023.
PMID: 36408618
Free PMC article.
Clinical Trial.
Item in Clipboard
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS.
Overton ET, Lawrence SJ, Stapleton JT, Weidenthaler H, Schmidt D, Koenen B, Silbernagl G, Nopora K, Chaplin P.
Overton ET, et al. Among authors: silbernagl g.
Vaccine. 2020 Mar 4;38(11):2600-2607. doi: 10.1016/j.vaccine.2020.01.058. Epub 2020 Feb 11.
Vaccine. 2020.
PMID: 32057574
Clinical Trial.
Item in Clipboard
Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial.
Samy N, Reichhardt D, Schmidt D, Chen LM, Silbernagl G, Vidojkovic S, Meyer TP, Jordan E, Adams T, Weidenthaler H, Stroukova D, De Carli S, Chaplin P.
Samy N, et al. Among authors: silbernagl g.
Vaccine. 2020 Mar 4;38(11):2608-2619. doi: 10.1016/j.vaccine.2020.01.055. Epub 2020 Feb 11.
Vaccine. 2020.
PMID: 32057576
Clinical Trial.
Item in Clipboard
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR, Hahn M, Lee HS, Koca C, Samy N, Schmidt D, Hornung J, Weidenthaler H, Heery CR, Meyer TPH, Silbernagl G, Maclennan J, Chaplin P.
Pittman PR, et al. Among authors: silbernagl g.
N Engl J Med. 2019 Nov 14;381(20):1897-1908. doi: 10.1056/NEJMoa1817307.
N Engl J Med. 2019.
PMID: 31722150
Clinical Trial.
Item in Clipboard
The epidemiology of infectious diseases in Europe in 2020 versus 2017-2019 and the rise of tick-borne encephalitis (1995-2020).
Jenkins VA, Silbernagl G, Baer LR, Hoet B.
Jenkins VA, et al. Among authors: silbernagl g.
Ticks Tick Borne Dis. 2022 Sep;13(5):101972. doi: 10.1016/j.ttbdis.2022.101972. Epub 2022 May 23.
Ticks Tick Borne Dis. 2022.
PMID: 35662067
Free PMC article.
Item in Clipboard
Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
Jordan E, Lawrence SJ, Meyer TPH, Schmidt D, Schultz S, Mueller J, Stroukova D, Koenen B, Gruenert R, Silbernagl G, Vidojkovic S, Chen LM, Weidenthaler H, Samy N, Chaplin P.
Jordan E, et al. Among authors: silbernagl g.
J Infect Dis. 2021 Mar 29;223(6):1062-1072. doi: 10.1093/infdis/jiaa460.
J Infect Dis. 2021.
PMID: 32726422
Clinical Trial.
Item in Clipboard
Cite
Cite